Perigon Wealth Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Perigon Wealth Management, LLC

  • $3.67 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$24.15 - $31.45 $30,670 - $39,941
-1,270 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$17.7 - $25.81 $22,479 - $32,778
1,270 New
1,270 $32,000
Q2 2018

Aug 07, 2018
SELL
$44.1 - $59.85 $73,823 - $100,188
-1,674 Closed
0 $0
Q3 2017

Dec 05, 2017
BUY
$36.75 - $49.65 $61,519 - $83,114
1,674
1,674 $67,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.96B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email